Results 61 to 70 of about 546,200 (199)

Four patients with a history of acute exacerbations of COPD: implementing the CHEST/Canadian Thoracic Society guidelines for preventing exacerbations [PDF]

open access: yes, 2015
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if ...
A Singanayagam   +43 more
core   +1 more source

Chronic Obstructive Pulmonary Disease

open access: yesVeterinary Clinics of North America: Equine Practice, 1991
COPD continues to be a severe condition in horses. Despite increased understanding of its pathogenesis, there is relatively little information on effective treatment regimens. Management and prevention are critical, and more emphasis should be placed on improved housing, bedding, and feeding.
openaire   +2 more sources

Adoption and adherence to chronic obstructive pulmonary disease GOLD guidelines in a primary care setting

open access: yesSAGE Open Medicine, 2019
Objectives: Over 380 million people in the world live with chronic obstructive pulmonary disease, and it is the third leading cause of death in the United States. Despite updated guidelines, there may be significant variations in diagnosis and management
Salim Surani   +8 more
doaj   +1 more source

Systematic review on inhaled corticosteroid monotherapy and its efficacy and safety in longterm treatment of patients with chronic obstructive pulmonary disease (COPD) [PDF]

open access: yes
--chronic obstructive pulmonary disease,COPD,corticosteroids,systematic review,chronisch obstruktive Lungenerkrankung,COPD,Kortikosteroid,systematischer ...
Buchberger, Barbara   +4 more
core  

The activity of antioxidant enzymes in chronic obstructive pulmonary disease in combination with comorbid obesity [PDF]

open access: yes, 2013
Background. Chronic obstructive pulmonary disease (COPD) is one of the most common diseases in the world, whose mortality continues to increase. The focus of modern medical science and public health is obesity too, because the number of patients are ...
Fediv, O.I., Stupnytska, G.Y.
core  

The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study) [PDF]

open access: yes, 2016
Background: Tiotropium + olodaterol has demonstrated improvements beyond lung function benefits in a large Phase III clinical program as a once-daily maintenance treatment for COPD and may be a potential option for the initiation of maintenance treatment
Beeh, Kai-Michael   +8 more
core   +2 more sources

Multi-morbidities are Not a Driving Factor for an Increase of COPD-Related 30-Day Readmission Risk [PDF]

open access: yes, 2020
Background and Objective: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States. COPD is expensive to treat, whereas the quality of care is difficult to evaluate due to the high prevalence of multi ...
Chukmaitov, Askar   +3 more
core   +1 more source

The efficacy of psychologically based interventions to improve anxiety, depression and quality of life in COPD: a systematic review and meta-analysis [PDF]

open access: yes, 2012
This article comprises a systematic review and meta-analysis looking at the efficacy of psychological intervention in improving anxiety, depression and quality of life in respiratory disease.Objective: To systematically evaluate the efficacy of ...
Adams   +47 more
core   +2 more sources

Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony

open access: yesCardiovascular Diabetology, 2012
Chronic obstructive pulmonary disease, metabolic syndrome and diabetes mellitus are common and underdiagnosed medical conditions. It was predicted that chronic obstructive pulmonary disease will be the third leading cause of death worldwide by 2020.
Mirrakhimov Aibek E
doaj   +1 more source

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. [PDF]

open access: yes, 2014
BACKGROUND: Inhaled corticosteroids (ICS) are anti-inflammatory drugs that have proven benefits for people with worsening symptoms of chronic obstructive pulmonary disease (COPD) and repeated exacerbations.
Agarwal   +163 more
core   +1 more source

Home - About - Disclaimer - Privacy